IDiyas

For the Inventor, By the Inventor

Vernon Hills, IL, United States of America

Nathaniel Catron

USPTO Granted Patents = 12 

Average Co-Inventor Count = 4.9

ph-index = 4

Forward Citations = 47(Granted Patents)


Company Filing History:

goldMedal12 out of 822 
 
Abbvie Inc.
 patents

Years Active: 2013-2020

Loading Chart...
12 patents (USPTO):
1. 10730873 - Salts and crystalline forms of an apoptosis-inducing agent (2020-08-04),
2. 10213433 - Solid dispersions containing an apoptosis-inducing agent (2019-02-26),
3. 9840502 - Salts and crystalline forms of an apoptosis-inducing agent (2017-12-12),
4. 9403822 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2016-08-02),
5. 9238649 - Salts and crystalline forms of 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide (2016-01-19),
6. 9006247 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2015-04-14),
7. 8927009 - ABT-263 capsule (2015-01-06),
8. 8728516 - Stabilized lipid formulation of apoptosis promoter (2014-05-20),
9. 8722657 - Salts and crystalline forms of an apoptosis-inducing agent (2014-05-13),
10. 8513243 - ABT-263 crystalline forms (2013-08-20),
11. 8362014 - ABT-263 crystalline forms (2013-01-29),
12. 8362013 - Salt of ABT-263 and solid-state forms thereof (2013-01-29),

Title: Nathaniel Catron: Innovator in Pharmaceutical Development

Introduction

Nathaniel Catron is a prominent inventor based in Vernon Hills, Illinois. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that induce apoptosis in cancer cells. With a total of 12 patents to his name, Catron's work is at the forefront of innovative cancer treatments.

Latest Patents

Among his latest patents, Catron has developed salts and crystalline forms of an apoptosis-inducing agent. This invention includes a compound that serves as an active pharmaceutical ingredient, which is particularly useful in treating diseases characterized by the overexpression of anti-apoptotic Bcl-2 family proteins, such as cancer. Another notable patent involves solid dispersions containing a pro-apoptotic solid dispersion, which comprises a Bcl-2 family protein inhibitory compound. This solid dispersion is designed for oral administration and aims to provide effective treatment options for patients suffering from cancer.

Career Highlights

Nathaniel Catron is currently employed at AbbVie Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on creating effective treatments that target cancer cells, thereby improving patient outcomes. His extensive research and development efforts have positioned him as a key player in the industry.

Collaborations

Throughout his career, Catron has collaborated with notable colleagues, including Geoff G Z Zhang and Shuang Chen. These partnerships have facilitated the advancement of his research and the successful development of his patented inventions.

Conclusion

Nathaniel Catron's contributions to pharmaceutical innovation are significant and impactful. His dedication to developing effective cancer treatments through his patented inventions showcases his commitment to improving healthcare. His work continues to inspire advancements in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…